Imagine this: more people are beating cancer, and that's great news. But it also means hospitals are stretched thin trying to keep up with follow-up care. So, what if general practitioners, or GPs, stepped in to help? That's the idea being tossed around. Let's dive into what specialists thi
Medical decisions are tricky. Everyone is different, and what works for one person might not work for another. This is especially true when considering patient preferences. So, how can doctors make the best choices for each individual? Well, a clever solution has been developed. It's a flexible syst
When it comes to colorectal cancer, the immune system is a big player. One type of immune cell, called naïve CD4 T cells, is especially important. These cells are like new recruits in the immune system's army, ready to fight off invaders. But their role in colorectal cancer is not as clear-cut as it
Public health experts often team up with faith communities to boost health outcomes. This review looks at how these experts have reached out to these communities. It uses a specific theory to judge these efforts. The review focuses on three big topics: vaccines, genetic health, and colorectal cance
Microbe detectives dilemmas Colon cancer, unfortunately , affects so many globally. The gut microbiome plays a suspiciously important part in as there is an entire universe living in our guts. Let's learn then about how this microscopic world makes you cancer-rate. So each microbe inhabits a librar
Ever wondered how some people beat a cancer diagnosis due to detecting it early? A lot of genes can be linked to cancer. For many years, CRC, or colorectal cancer, has started to creep up among young adults. This has brought about an increase in research conducted on the 5 percent of cases which ha
Colorectal cancer is a tricky enemy, with mutations in proteins like APC and AXIN boosting the Wnt/β-catenin pathway. The Wnt/β-catenin pathway is a key player in tumor growth and spreading. The pathway can be turned on in an unwanted way, leading to a buildup of β-catenin. This buildup is caused by
Metastatic colorectal cancer (mCRC) is a challenge for doctors. It is important to try to keep patients' quality of life while also extending their lives. Doctors also want to avoid harmful side effects. We have several treatments, but choosing the right one can be tricky, especially since differen
The need to find new treatment options for patients with advanced colon cancer has always been a challenge for doctors. The medical community has been using a combination of FOLFOXIRI and bevacizumab as a first line treatment. This is a potent cocktail of chemotherapy drugs that fight cancer cells i
Every now and then, scientists discover something in nature that punches above its weight. PD15, a special chemical from a plant called Paris delavayi, is one of those surprises. It's like a tiny powerhouse that's really good at killing colorectal cancer cells. But how does it do that? Well, PD15 ha
